PMID- 23319318 OWN - NLM STAT- MEDLINE DCOM- 20140130 LR - 20161125 IS - 1095-8355 (Electronic) IS - 1065-6995 (Linking) VI - 37 IP - 1 DP - 2013 Jan TI - Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells. PG - 19-28 LID - 10.1002/cbin.10003 [doi] AB - Atherosclerosis develops from cascades of inflammatory processes. Spleen tyrosine kinase (Syk) and monocyte chemotatic protein-1 (MCP-1) play important roles in the pathogenesis of atherosclerosis. Mycophenolic acid (MPA) has an anti-inflammatory effect. We have investigated whether MPA regulates Syk to repress tumour necrosis factor-alpha (TNF-alpha)-induced MCP-1 production in cultured human aortic endothelial cells. Expression of MCP-1 mRNA and its protein were measured by real time RT-PCR and ELISA, respectively. Reactive oxygen species (ROS) production were measured using 2'7'-dichlorofluorescein diacetate. Activation of AP-1 and NF-kappaB were assessed by electrophoretic mobility shift assay. Tyrosine phosphorylation of Syk was examined by Western blot analysis. TNF-alpha increased MCP-1 at both mRNA and protein levels. TNF-alpha-induced MCP-1 mRNA expression was inhibited by N-acetylcysteine (NAC), Syk inhibitor, Syk-siRNA and MPA. TNF-alpha-induced MCP-1 protein production was also inhibited by Syk inhibitor and MPA. TNF-alpha increased DNA binding activity of AP-1 and NF-kappaB, whereas both AP-1 and NF-kappaB decoy oligodeoxynucleotides downregulated TNF-alpha-induced MCP-1 mRNA expression. TNF-alpha increased ROS generation, which was inhibited by NAC and MPA, but not by Syk inhibitor. TNF-alpha increased tyrosine phosphorylation of Syk, which was attenuated by NAC and MPA. MPA and Syk inhibitor attenuated TNF-alpha-induced DNA binding activity of NF-kappaB and AP-1. TNF-alpha induced MCP-1 expression via activation of AP-1 and NF-kappaB. AP-1 and NF-kappaB were mediated through ROS, followed by Syk. MPA exerts anti-inflammatory effect by inhibiting MCP-1 expression via suppression of ROS and Syk. CI - (c) 2012 International Federation for Cell Biology. FAU - Koo, Tai Yeon AU - Koo TY AD - Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea. FAU - Kim, Yoon Ji AU - Kim YJ FAU - Yang, Won Seok AU - Yang WS FAU - Park, Jung Sik AU - Park JS FAU - Han, Nam Jeong AU - Han NJ FAU - Lee, Joo Mi AU - Lee JM FAU - Park, Su Kil AU - Park SK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121204 PL - England TA - Cell Biol Int JT - Cell biology international JID - 9307129 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Chemokine CCL2) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (NF-kappa B) RN - 0 (Reactive Oxygen Species) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (SYK protein, human) RN - EC 2.7.10.2 (Syk Kinase) RN - HU9DX48N0T (Mycophenolic Acid) SB - IM MH - Anti-Inflammatory Agents/*pharmacology MH - Aorta/cytology/metabolism MH - Chemokine CCL2/*biosynthesis MH - Endothelial Cells/cytology/*drug effects/metabolism MH - Endothelium, Vascular/cytology/metabolism MH - Humans MH - Intracellular Signaling Peptides and Proteins/*genetics/metabolism MH - Mycophenolic Acid/*pharmacology MH - NF-kappa B/metabolism MH - Protein-Tyrosine Kinases/*genetics/metabolism MH - Reactive Oxygen Species/metabolism MH - Signal Transduction MH - Syk Kinase MH - Tumor Necrosis Factor-alpha/antagonists & inhibitors/*genetics/metabolism EDAT- 2013/01/16 06:00 MHDA- 2014/01/31 06:00 CRDT- 2013/01/16 06:00 PHST- 2012/01/16 00:00 [received] PHST- 2012/09/14 00:00 [accepted] PHST- 2013/01/16 06:00 [entrez] PHST- 2013/01/16 06:00 [pubmed] PHST- 2014/01/31 06:00 [medline] AID - 10.1002/cbin.10003 [doi] PST - ppublish SO - Cell Biol Int. 2013 Jan;37(1):19-28. doi: 10.1002/cbin.10003. Epub 2012 Dec 4.